Trial Profile
Double Blind, Double-Dummy, Randomised, Placebo Controlled Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs Vofopitant (Primary) ; Lamotrigine
- Indications Bipolar disorders; Epilepsy; Lennox-Gastaut syndrome; Partial epilepsies; Tonic-clonic epilepsy
- Focus Pharmacodynamics
- Sponsors GSK
- 01 Apr 2011 Planned end date changed from 1 Oct 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 01 Apr 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Mar 2010 Planned end date changed from 1 Oct 2009 to 1 Oct 2010 as reported by ClinicalTrials.gov.